Clinical Trial

Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome

Name: Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome — clinical trial record (NCT07388810)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This is an open-label randomized controlled trial to evaluate the efficacy and safety of one dose versus two doses of ripertamab in children with frequent relapses or steroid-dependent nephrotic syndrome (FRNS/SDNS).

Trial Details

NCT Number	NCT07388810
Lead Sponsor	Mao Jianhua Collaborators: Sinocelltech Ltd.
Conditions	FRNS/SDNS, Ripertamab
Enrollment	312 participants
Start Date	2026-02
Primary Completion	2026-12 (estimated)
Study Completion	2028-02 (estimated)
Updated on ClinicalTrials.gov	2026-02-05